The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.125.8.1063

Earlier studies of the effectiveness of metronidazole in treating alcoholism have reported divergent findings. The authors tested the drug vs. placebo in a long-term, double-blind study of 100 alcoholic patients; the drug failed to demonstrate a significant positive effect on abstinence. The only positive finding was a "metronidazole effect"—a decreased desire for and tolerance of alcohol—which was slightly linked with treatment success. The authors suggest that metronidazole may be useful as an adjunct to therapy with patients who develop this effect.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.